Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98


Is the Kinect system suitable for evaluation of the hip joint range of motion and as a screening tool for femoroacetabular impingement (FAI)?

Lahner M, Mußhoff D, von Schulze Pellengahr C, Willburger R, Hagen M, Ficklscherer A, von Engelhardt LV, Ackermann O, Lahner N, Vetter G.

Technol Health Care. 2015;23(1):75-81. doi: 10.3233/THC-140870.


Recommendations for treating adult and geriatric patients on multimedication.

Bergert FW, Braun M, Ehrenthal K, Feßler J, Gross J, Hüttner U, Kluthe B, Liesenfeld A, Seffrin J, Vetter G, Beyer M, Muth C, Popert U, Harder S, Kirchner H, Schubert I.

Int J Clin Pharmacol Ther. 2014 Oct;52 Suppl 1:1-64. No abstract available.


Aggressive Breast Cancer during Pregnancy with a Rare Form of Metastasis in the Maternal Placenta.

Vetter G, Zimmermann F, Bruder E, Schulzke S, Hösli I, Vetter M.

Geburtshilfe Frauenheilkd. 2014 Jun;74(6):579-582.


The role of arthroscopy in patients with persistent hip pain after total hip arthroplasty.

Lahner M, von Schulze Pellengahr C, Lichtinger TK, Vetter G, Pesendorfer SH, Hagen M, Daniilidis K, von Engelhardt LV, Teske W.

Technol Health Care. 2013;21(6):599-606. doi: 10.3233/THC-130761.


Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model.

Banyard J, Chung I, Wilson AM, Vetter G, Le Béchec A, Bielenberg DR, Zetter BR.

Sci Rep. 2013 Nov 6;3:3151. doi: 10.1038/srep03151.


The deviation of the mechanical leg axis correlates with an increased hip alpha angle and could be a predictor of femoroacetabular impingement.

Lahner M, Jahnke NL, Zirke S, Teske W, Vetter G, von Schulze Pellengahr C, Daniilidis K, Hagen M, von Engelhardt LV.

Int Orthop. 2014 Jan;38(1):19-25. doi: 10.1007/s00264-013-2085-0. Epub 2013 Sep 14.


Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells.

Saumet A, Vetter G, Bouttier M, Antoine E, Roubert C, Orsetti B, Theillet C, Lecellier CH.

Mol Biosyst. 2012 Oct 30;8(12):3242-53. doi: 10.1039/c2mb25298h.


Fibronectin 1 protein expression in clear cell renal cell carcinoma.

Steffens S, Schrader AJ, Vetter G, Eggers H, Blasig H, Becker J, Kuczyk MA, Serth J.

Oncol Lett. 2012 Apr 1;3(4):787-790. Epub 2012 Jan 12.


A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition.

Moes M, Le Béchec A, Crespo I, Laurini C, Halavatyi A, Vetter G, Del Sol A, Friederich E.

PLoS One. 2012;7(4):e35440. doi: 10.1371/journal.pone.0035440. Epub 2012 Apr 13.


Caveolin 1 protein expression in renal cell carcinoma predicts survival.

Steffens S, Schrader AJ, Blasig H, Vetter G, Eggers H, Tränkenschuh W, Kuczyk MA, Serth J.

BMC Urol. 2011 Dec 7;11:25. doi: 10.1186/1471-2490-11-25.


Factors influencing endothelial function in healthy pre- and post-menopausal women of the EU-RISC study.

Konrad T, Bär F, Schneider F, Franke S, Böhles H, Vetter G, Balkau B.

Diab Vasc Dis Res. 2011 Jul;8(3):229-36. doi: 10.1177/1479164111416139. Epub 2011 Jul 11.


MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model.

Le Béchec A, Portales-Casamar E, Vetter G, Moes M, Zindy PJ, Saumet A, Arenillas D, Theillet C, Wasserman WW, Lecellier CH, Friederich E.

BMC Bioinformatics. 2011 Mar 4;12:67. doi: 10.1186/1471-2105-12-67.


[Cementless hip replacement: indications, postoperative treatment, sports].

Engelhardt LV, Vetter G, Teske W, Lichtinger TK, Pellengahr Cv.

MMW Fortschr Med. 2010 Oct 28;152(43):33-5. German. No abstract available.


Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.

Waalkes S, Atschekzei F, Kramer MW, Hennenlotter J, Vetter G, Becker JU, Stenzl A, Merseburger AS, Schrader AJ, Kuczyk MA, Serth J.

BMC Cancer. 2010 Sep 22;10:503. doi: 10.1186/1471-2407-10-503.


miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.

Vetter G, Saumet A, Moes M, Vallar L, Le Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH, Friederich E.

Oncogene. 2010 Aug 5;29(31):4436-48. doi: 10.1038/onc.2010.181. Epub 2010 Jun 14.


Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients.

Konrad T, Franke S, Schneider F, Bär F, Vetter G, Winkler K.

J Hum Hypertens. 2011 Jan;25(1):18-24. doi: 10.1038/jhh.2010.23. Epub 2010 Mar 18.


The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner.

Janji B, Vallar L, Al Tanoury Z, Bernardin F, Vetter G, Schaffner-Reckinger E, Berchem G, Friederich E, Chouaib S.

J Cell Mol Med. 2010 Jun;14(6A):1264-75. doi: 10.1111/j.1582-4934.2009.00918.x. Epub 2009 Oct 3.


Time-resolved analysis of transcriptional events during SNAI1-triggered epithelial to mesenchymal transition.

Vetter G, Le Béchec A, Muller J, Muller A, Moes M, Yatskou M, Al Tanoury Z, Poch O, Vallar L, Friederich E.

Biochem Biophys Res Commun. 2009 Aug 7;385(4):485-91. doi: 10.1016/j.bbrc.2009.05.025. Epub 2009 May 12.


Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia.

Saumet A, Vetter G, Bouttier M, Portales-Casamar E, Wasserman WW, Maurin T, Mari B, Barbry P, Vallar L, Friederich E, Arar K, Cassinat B, Chomienne C, Lecellier CH.

Blood. 2009 Jan 8;113(2):412-21. doi: 10.1182/blood-2008-05-158139. Epub 2008 Oct 21.


Advanced spot quality analysis in two-colour microarray experiments.

Yatskou M, Novikov E, Vetter G, Muller A, Barillot E, Vallar L, Friederich E.

BMC Res Notes. 2008 Sep 17;1:80. doi: 10.1186/1756-0500-1-80.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk